We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$207M
AUM Growth
+$72.1M
Cap. Flow
+$59.3M
Cap. Flow %
28.65%
Top 10 Hldgs %
47.42%
Holding
159
New
12
Increased
64
Reduced
2
Closed
5

Sector Composition

Rank Sector Weight
1 Energy 63.86%
2 Healthcare 21.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCP
26
DELISTED
TC Pipelines LP
TCP
$1.33M 0.64%
23,352
+7,833
+50% +$424K
WES icon
27
Western Midstream Partners
WES
$19.8B
$1.32M 0.64%
30,996
+10,394
+50% +$392K
UBT icon
28
ProShares Ultra 20+ Year Treasury
UBT
$58M
$1.24M 0.6%
+25,520
New +$1.26M
SHLX
29
DELISTED
Shell Midstream Partners, L.P.
SHLX
$1.23M 0.59%
38,250
+12,825
+50% +$404K
VNQ icon
30
Vanguard Real Estate ETF
VNQ
$39.1B
$1.21M 0.59%
+13,991
New +$1.25M
EXEL icon
31
Exelixis
EXEL
$14B
$1.09M 0.53%
84,932
+10,702
+14% +$116K
ARIA
32
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.04M 0.5%
75,645
+9,532
+14% +$95.7K
RPTP
33
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$1.02M 0.49%
114,022
+14,368
+14% +$102K
IONS icon
34
Ionis Pharmaceuticals
IONS
$9.23B
$1.02M 0.49%
27,856
+3,511
+14% +$110K
TBPH icon
35
Theravance Biopharma
TBPH
$874M
$1.01M 0.49%
27,829
+3,506
+14% +$97.6K
VNDA icon
36
Vanda Pharmaceuticals
VNDA
$322M
$957K 0.46%
57,536
+7,249
+14% +$97.6K
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
$865K 0.42%
16,008
+2,017
+14% +$95.6K
PGNX
38
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$857K 0.41%
135,340
+17,055
+14% +$103K
HALO icon
39
Halozyme
HALO
$9.59B
$847K 0.41%
70,108
+8,834
+14% +$90.3K
TVTX icon
40
Travere Therapeutics
TVTX
$5.27B
$841K 0.41%
37,593
+4,736
+14% +$90.2K
ENLC
41
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$836K 0.4%
49,935
+16,745
+50% +$272K
SE
42
DELISTED
Spectra Energy Corp Wi
SE
$818K 0.4%
19,142
+2,831
+17% +$108K
BIIB icon
43
Biogen
BIIB
$29.6B
$806K 0.39%
2,575
+324
+14% +$96K
SRPT icon
44
Sarepta Therapeutics
SRPT
$1.68B
$795K 0.38%
12,949
TRGP icon
45
Targa Resources
TRGP
$61.3B
$769K 0.37%
15,655
-9,908
-39% -$430K
IRWD icon
46
Ironwood Pharmaceuticals
IRWD
$624M
$768K 0.37%
57,756
+7,277
+14% +$85.1K
INCY icon
47
Incyte
INCY
$23.3B
$736K 0.36%
7,804
+984
+14% +$82.9K
ICPT
48
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$721K 0.35%
4,378
+552
+14% +$87K
BMRN icon
49
BioMarin Pharmaceuticals
BMRN
$11.4B
$711K 0.34%
7,681
+968
+14% +$91.2K
NKTR icon
50
Nektar Therapeutics
NKTR
$2.34B
$711K 0.34%
2,758
+348
+14% +$89.6K

Similar funds

Virtus ETF Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, Virtus ETF Advisers held 159 positions worth $207M, up 53% from $135M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Virtus ETF Advisers deployed $59.3M of net new capital in Q3 2016, opening 12 new positions and adding to 64 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, down from 64% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Williams Companies, an estimated $4.42M trimmed.

  • Virtus ETF Advisers's largest Q3 2016 buy was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q3 2016, an estimated $6.79M increase.
  • Virtus ETF Advisers's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $4.42M.
  • Virtus ETF Advisers fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $546K.
  • Virtus ETF Advisers's ten largest holdings make up 47% of its $207M portfolio in Q3 2016.
  • Virtus ETF Advisers opened 12 new positions and closed 5 in Q3 2016.
  • Virtus ETF Advisers's portfolio value rose 53% quarter-over-quarter to $207M.

Based on Virtus ETF Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.